Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

National Coverage of Reflex Cryptococcal Antigen Screening: A Milestone Achievement in the Care of Persons With Advanced HIV Disease

South African Medical Journal
Medicine
2018English

HCC Screening Is Associated With Survival Benefit in the in an Silico but Needs Confirmation in an Vivo Analysis

Hepatology
MedicineHepatology
2018English

Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-Of-Care Laboratory Testing

Journal of Clinical Microbiology
Microbiology
2018English

Establishing a Cost-Per-Result of Laboratory-Based, Reflex Cryptococcal Antigenaemia Screening (CrAg) in HIV+ Patients With CD4 Counts Less Than 100 Cells/Μl Using a Lateral Flow Assay (LFA) at a Typical Busy CD4 Laboratory in South Africa

PLoS ONE
Multidisciplinary
2017English

Β-Blockers Associated With No Class-Specific Survival Benefit in Acute Intracerebral Hemorrhage

Journal of the Neurological Sciences
Neurology
2014English

Rapid Detection of Cryptococcal Antigen by a Flow Assay

Microbiologia Medica
2017English

Factors Associated With Early Mycological Clearance in HIV-associated Cryptococcal Meningitis

PLoS ONE
Multidisciplinary
2017English

Dramatic Survival Benefit With Nivolumab in Melanoma

Cancer Discovery
Oncology
2016English

Tax-Benefit Microsimulation Modelling in Tanzania: A Feasibility Study

WIDER Working Paper
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy